Cervical Length Pre-induction as a Tool to Predict Vaginal Birth

Pregnancy, Prolonged Clinical Trial

Official title:

Use of Cervical Length Previous to the Use of Prostaglandins as a Tool to Predict Vaginal Birth in Pregnancies With > 41 Weeks Gestation.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02916082
• Other study ID #: 2015-288V2
• Status: Completed
• Phase: N/A
• First received: September 25, 2016
• Last updated: September 25, 2016
• Start date: November 2015
• Est. completion date: August 2016

Study information

• Verified date: September 2016
• Source: Saint Thomas Hospital, Panama
• Contact: n/a
• Is FDA regulated: No
• Health authority: Panama: Ministry of Health
• Study type: Observational

Clinical Trial Summary

To evaluate the value of measuring cervical length as a predictor of vaginal birth after induction of labor with prostaglandins in pregnancies with 41 weeks of gestation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: August 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• 41 weeks or more of gestational age

• Cervical length measured by a FMF certified physician

Exclusion Criteria:

• Any condition that could interfere with a possible vaginal birth (previous cesarean section, hypertensive disorders of pregnancies).

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cervical Length Measurement
• Pregnancy, Prolonged

Intervention

Procedure:
• Cervical length measurement
Vaginal ultrasound to measure cervical length previous to use of prostaglandins.

Locations

Country	Name	City	State
Panama	Saint Thomas H	Panama

Sponsors (1)

Lead Sponsor	Collaborator
Saint Thomas Hospital, Panama

Country where clinical trial is conducted

Panama, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Vaginal Birth	Number of vaginal births obtained after a measure of cervical length below 2,5 cms.	72 hours	No
Secondary	Induction to delivery time	Time (hours) between the application of a prostaglandin and termination of pregnancy (vaginal or cesarean).	72 hours	No